Unknown

Dataset Information

0

Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.


ABSTRACT:

Background

Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre-stored HLA information obtained from other clinical workups has not been used to prevent ADRs. We aimed to simulate the preemptive use of pre-stored HLA information in electronic medical records to evaluate whether this information can prevent ADRs.

Methods

We analyzed the incidence and the risk of ADRs for selected HLA alleles (HLA-B*57:01, HLA-B*58:01, HLA-A*31:01, HLA-B*15:02, HLA-B*15:11, HLA-B*13:01, HLA-B*59:01, and HLA-A*32:01) and seven drugs (abacavir, allopurinol, carbamazepine, oxcarbazepine, dapsone, methazolamide, and vancomycin) using pre-stored HLA information of transplant patients based on the Pharmacogenomics Knowledge Base guidelines and experts' consensus.

Results

Among 11,988 HLA-tested transplant patients, 4092 (34.1%) had high-risk HLA alleles, 4583 (38.2%) were prescribed risk drugs, and 580 (4.8%) experienced type B ADRs. Patients with HLA-B*58:01 had a significantly higher incidence of type B ADR and SCARs associated with allopurinol use than that of patients without HLA-B*58:01 (17.2% vs. 11.9%, odds ratio [OR] 1.53 [95% confidence interval {CI} 1.09-2.13], p = 0.001, 2.3% versus 0.3%, OR 7.13 [95% CI 2.19-22.69], p < 0.001). Higher risks of type B ADR and SCARs were observed in patients taking carbamazepine or oxcarbazepine if they had one of HLA-A*31:01, HLA-B*15:02, or HLA-B*15:11 alleles. Vancomycin and dapsone use in HLA-A*32:01 and HLA-B*13:01 carriers, respectively, showed trends toward increased risk of type B ADRs.

Conclusion

Utilization of pre-stored HLA data can prevent type B ADRs including SCARs by screening high-risk patients.

SUBMITTER: Lee KH 

PROVIDER: S-EPMC8760506 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.

Lee Kye Hwa KH   Kang Dong Yoon DY   Kim Hyun Hwa HH   Kim Yi Jun YJ   Kim Hyo Jung HJ   Kim Ju Han JH   Song Eun Young EY   Yun James J   Kang Hye-Ryun HR  

Clinical and translational allergy 20220114 1


<h4>Background</h4>Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre-stored HLA information obtained from other clinical workups has not been used to prevent ADRs. We aimed to simulate the preemptive use of pre-stored HLA information in electronic medical records to evaluate whether this information can prevent ADRs.<h4>Methods</h4>We analyzed the incidence and  ...[more]

Similar Datasets

| S-EPMC6676067 | biostudies-literature
| S-EPMC8602035 | biostudies-literature
| S-EPMC7840880 | biostudies-literature
| S-EPMC9389100 | biostudies-literature
| S-EPMC6687717 | biostudies-literature
| S-EPMC9976545 | biostudies-literature
| S-EPMC6340804 | biostudies-literature
| S-EPMC6039997 | biostudies-other
2024-09-18 | GSE275871 | GEO
| S-EPMC6342723 | biostudies-literature